All Clinical Trials

Clinical Trial

Biologic effects and efficacy of Cerebellar tDCS in Children with Autism Spectrum Disorder

  • Recruiting participants (Starts Jan. 21, 2019)
  • Not accepting healthy volunteers
  • UTSW Principal Investigator: PETER TZU-SHIN TSAI

summary

Please refer to Section 3 of the protocol (Concise Summary of Project).

objective

Please refer to protocol sections "introduction and Purpose," "Background," "autism and the cerebellum," "non-invasive brain stimulation and autism," and "cerebellar non-invasive stimulation."

eligibility

-Ages 4 to 17, male and female, with known autism spectrum disorder as diagnosed by a clinician -This study may expose unborn children to risks, so females must not be pregnant. Approximately 30 milliliters of urine will be collected from females in the study for a pregnancy test. -- IQ Score no less than 1.5 Standard Deviations below the mean - Language Level (Speech consists of, at minimum, flexible, spontaneous, simple, sentences.)

If you are interested in this clinical trial, please contact Amy Magallanes on the Children’s Health Research Team.Call 214-648-5155Email